X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (2) 2
female (2) 2
hematology, oncology and palliative medicine (2) 2
humans (2) 2
index medicus (2) 2
middle aged (2) 2
oncology (2) 2
therapy (2) 2
abdomen (1) 1
abridged index medicus (1) 1
adp (1) 1
adult (1) 1
advanced adv nsclc (1) 1
alanine (1) 1
analysis (1) 1
anemia (1) 1
anti-pd1 (1) 1
anticancer properties (1) 1
antitumor activity (1) 1
aspartate aminotransferase (1) 1
bevacizumab (1) 1
biomarkers (1) 1
breast cancer (1) 1
cancer (1) 1
cancer therapies (1) 1
carcinoma (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
care and treatment (1) 1
central nervous metastases (1) 1
central nervous system (1) 1
chemoradiotherapy (1) 1
chemotherapy (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
cisplatin - adverse effects (1) 1
clinical trials (1) 1
combination (1) 1
concomitant chemoradiotherapy (1) 1
consolidation chemotherapy (1) 1
disease progression (1) 1
disease-free survival (1) 1
docetaxel (1) 1
double-blind method (1) 1
drug therapy (1) 1
epithelial ovarian (1) 1
etoposide (1) 1
fallopian tube (1) 1
follow-up studies (1) 1
genomes (1) 1
hemoglobin (1) 1
heterozygosity (1) 1
homologous recombination (1) 1
homologous recombination repair (1) 1
homology (1) 1
indoles - administration & dosage (1) 1
induction chemotherapy (1) 1
inhibitors (1) 1
internationality (1) 1
loss of heterozygosity (1) 1
lung neoplasms - mortality (1) 1
lung neoplasms - pathology (1) 1
lung neoplasms - therapy (1) 1
maintenance chemotherapy - methods (1) 1
male (1) 1
medicine & public health (1) 1
medicine, general & internal (1) 1
metastases (1) 1
molecular targeted therapy - methods (1) 1
motivation (1) 1
multicenter (1) 1
mutation (1) 1
neoplasm recurrence, local - drug therapy (1) 1
neoplasm recurrence, local - mortality (1) 1
neoplasm recurrence, local - pathology (1) 1
neoplasm staging (1) 1
nivo (1) 1
nivolumab (1) 1
non-small cell lung cancer (1) 1
open-label (1) 1
oral vinorelbine (1) 1
original (1) 1
original article (1) 1
ovarian cancer (1) 1
ovarian carcinoma (1) 1
ovarian neoplasms - mortality (1) 1
ovarian neoplasms - pathology (1) 1
ovarian neoplasms - therapy (1) 1
paclitaxel (1) 1
pain (1) 1
patients (1) 1
patients pts (1) 1
performance status 2 (1) 1
peritoneum (1) 1
platinum (1) 1
point mutation (1) 1
poly (1) 1
poly polymerase (1) 1
poly polymerase inhibitors - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Coleman, Robert L and Coleman, R L and Oza, Amit M and Oza, A M and Lorusso, D and Lorusso, Domenica and Aghajanian, C and Aghajanian, Carol and Oaknin, A and Oaknin, Ana and Dean, A and Dean, Andrew and Colombo, N and Colombo, Nicoletta and Weberpals, Johanne I and Weberpals, J I and Clamp, Andrew and Clamp, A and Scambia, Giovanni and Scambia, G and Leary, A and Leary, Alexandra and Holloway, Robert W and Holloway, R W and Gancedo, M Amenedo and Gancedo, Margarita Amenedo and Fong, Peter C and Fong, P C and Goh, Jeffrey C and Goh, J C and O'Malley, David M and O'Malley, D M and Armstrong, Deborah K and Armstrong, D K and Garcia-Donas, Jesus and Garcia-Donas, J and Swisher, E M and Swisher, Elizabeth M and Floquet, A and Floquet, Anne and Konecny, Gottfried E and Konecny, G E and McNeish, I A and McNeish, Iain A and Scott, C L and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, J A and Ledermann, Jonathan A and Buck, M and Friedlander, M L and Harnett, P and Kichenadasse, G and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Plante, M and Provencher, D and Welch, S and Gladieff, L and Joly, F and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Pignata, S and Sabbatini, R F and Tamberi, S and Zamagni, C and O'Donnell, A and Herraez, A Casado and Guerra, E M and Palacio, I and Romero, I and Sanchez, A and ... and ARIEL3 Investigators and ARIEL3 investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | ADP | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_5
Abstract Background In ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo and was associated with... 
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 09/2019, Volume 29, Issue Suppl 3, pp. A1 - A2
ObjectivesIn ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo. A prespecified exploratory analysis... 
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 11/2019, Volume 29, Issue Suppl 4, p. A27
Introduction/BackgroundIn ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo in all patient populations,... 
Journal Article
International Journal of Gynecologic Cancer, ISSN 1048-891X, 11/2019, Volume 29, Issue Suppl 4, p. A28
Introduction/BackgroundMaintenance therapy for recurrent ovarian cancer is intended to extend progression-free survival (PFS) without compromising patient... 
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.